Estela Sánchez-Herrero

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Sentinel Lymph Node

Epidermal Growth Factor Receptor

Neoadjuvant Chemotherapy

Top Venues

Advances in laboratory medicine

Clinical chemistry and laboratory medicine

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Mariano Provencio Pulla, Roberto Serna-Blasco, Ernest Nadal, Amelia Insa, Rosario Garcia Campelo, Joaquín Casal Rubio, Manuel Dómine, Margarita Majem, Delvys Rodriguez Abreu, Alex Martinez-Marti, Javier De Castro Carpeño, Manuel Cobo, Guillermo López Vivanco, Edel Del Barco, Reyes Bernabé Caro, Nuria Viñolas, Isidoro Barneto Aranda, Santiago Viteri, Eva Pereira, Juan-Antonio Vargas, Virginia Calvo, Javier Martín-López, Francisco García-García, Marta Casarrubios, Fernando F Franco, Estela Sánchez-Herrero, Bartomeu Massuti, Alberto Cruz-Bermúdez, Atocha Romero
Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non-Small-Cell Lung Cancer (NADIM phase II trial). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (25) (2022)
Clara Pérez-Barrios, Estela Sánchez-Herrero, Natalia Garcia-Simón, Miguel Barquín, Mariola Blanco Clemente, Mariano Provencio, Atocha Romero
ctDNA from body fluids is an adequate source for EGFR biomarker testing in advanced lung adenocarcinoma. Clinical chemistry and laboratory medicine 59 (7) (2021)
Estela Sánchez-Herrero, Mariano Provencio, Atocha Romero
Clinical utility of liquid biopsy for the diagnosis and monitoring of EML4-ALK NSCLC patients. Advances in laboratory medicine 1 (1) (2020)
Estela Sánchez-Herrero, Mariano Provencio, Atocha Romero
Clinical utility of liquid biopsy for the diagnosis and monitoring of EML4-ALK NSCLC patients. Advances in laboratory medicine 1 (1) (2020)